residential course on clinical pharmacology of ... january_01_di_perri.pdf · residential course on...
TRANSCRIPT
Residential Course on Clinical Pharmacology of Antiretrovirals
2005 – 2015
Gianni Di Perri
Clinica di Malattie InfettiveUniversità degli Studi di Torino
Ospedale Amedeo di Savoia
• This project took place following the development of a Laboratory of Pharmacokinetics inside the Infectious Diseases Unit of the University of Torino
• Based on the consideration that Torino hosted the third largest italian HIV case series per single clinical center, and that antiretroviral therapy should have been administered for the entire life, we decided to devote ourselves to the study of clinical pharmacology of antiretrovirals in order to try to better understand what we were doing to our patients
• The Residential Course on Clinical Pharmacology of Antiretrovirals has grown up in parallel with our genuine enthusiasm of working in such rapidly developing field, in which most of the novelties we have seen in the last 20 years really contributed to a longer and better life for our Patients
• The Residential Course in Clinical Pharmacology of Antiretrovirals, further to be a unique opportunity for us to learn from our Speakers and Participants, it’s a sort of celebration of our happiness to have You All here, to testify how good the idea was and still is, to annually assemble those, pharmacologists, clinicians and non-clinicians, who share the same passion for this special setting
Although the acknowledgments are usually done at the end, please let me anticipate my truly sincere gratitude to two particular Friends and Collaborators Who actually made their best efforts to make this project working….
Prof. Stefano Bonora Dr. Antonio D’Avolio
..together with Mauro Sciandra…
Dr. Margherita Bracchi
…..but at the very beginning, the very first move of this project was made together with…
Dr. Marta Boffito
..Who acted as pioneer in establishing our partnership with the David Back’s Pharmacology Group in Liverpool before migrating to the Chelsea HIV Unit in London….. We are still sad but truly proud as well!
…and on this line I am also very grateful to Dr. Lorena Baietto (PhD) for Her hard work in the Lab and the efforts She has made in teaching to students, technicians and postgraduates….
Dr. Lorena Baietto
More recently we also had the privilege to work with Dr. Marco Siccardi (PhD), Who graduated with us, and after having developed remarkable technical skills and successful scientific innovation also migrated to the UK where He joined the Pharmacology Group in Liverpool.We feel sadly proud, again….
Dr. Marco Siccardi
PIsN/NtRTIsNNRTIsEIsIIs
1987 1991-2 1994 1995
AZTddIddC d4T 3TC
Pre-HAART era
1996 1997 1998 1999
SQVRTVIDV
NVPNFVDLVEFV ABV APV
HAART era
2000 2002 2003 2005 2007 2008
LPV/r TDF
T20ATVFTC
fAPV TPV DRV Fighting against Drug - R
2008 2012 2013 2014
MVC
RALRPV DTG
MVC
RALETV
Long-termmanagement
EVGCOBIbooster
Pharmacology of ARVs: The
present and the future.
Torino Jan 2005
David Back
THE UNIVERSITY
of LIVERPOOL
HIV is a disease of long-term care
AZT
ddI
ddC
d4T
3TC ABCEFV
NVP
SQV
NFV
APV
RTVIDV
LPV/r
87 88 89 95 96 97 98 99 00 01
TDF
02 03
CBV TZV
ATV
3TC QD
ddI EC
EFV 600
Little Impact UnderstandingOver optimism Long-term care
Anti-HIV Therapy Treatment History
FTC
04
NRTIs
NNRTIs
Protease
Inhibitors
05
FTC/TDF
3TC/ABC
…. courtesy of David Back, 1st Residential Course on Clinical Pharmacology of Antiretrovirals, 2005
THE UNIVERSITY
of LIVERPOOL
How to quantify the “power” or “potency” of our PK exposure?
Plasma Ctrough
n. of relevant mutationsGIQ =
Plasma Ctrough
Virtual PhenotypeVIQ =
Patient IQ
Reference IQNIQ =
[c]
Drug [c] corresponding to the EC50
90%
Concentration measured
IQ
Plasma Ctrough
IC50-90
PIQ =
Pk exposure
Viral susceptibilityIQ =
In studies on PI-experienced pts. IQ has been repeatedly found to have a higher
predictive value than drug [c] or sensitivity testing taken alone
[c] ng/mL
1 2 3 4 5 6 n. PI mutations
11000
10000
9000
8000
7000
6000
5000
4000
3000
2000
1000
Median [c]
WT MEC
R1 MEC
R2 MEC
R3 MEC
R4 MEC
R5 MEC
R6 MEC
Unusual dosing:
- Superboosting
- Increased PI dose
- Both
The Future of HIV Pharmacology: Molecule to Man
Functional
genomics
Cell lines, viral infectivity
Intracellular PK,
sanctuary sites
Clinical efficacy &
interaction studies
Phenotype
GenotypePopulations
Man
Cells and Systems
Molecule
Gene
Studies
THE UNIVERSITY
of LIVERPOOL
0
20
40
60
80
100
120
140
160
2005 2006 2007 2009 2010 2011 2012 2013 2014 2015
PARTICIPANTS TO THE COURSE, 2005-2015
Stevan Jovetic was Liverpool's tormentor as he scored twice in Fiorentina's surprise win over the Reds in their Champions League Group E tie.
Page last updated at 20:35 GMT, Tuesday, 29 September 2009 21:35 UK
Fiorentina spoil Reds' swan songPublished: Thursday 10 December 2009, 0.30CETLiverpool FC 1-2 ACF FiorentinaAlberto Gilardino struck in injury time to complete a comeback win that sealed top spot for the Viola and a sorry Liverpool campaign.
Acknowledgments
THE UNIVERSITY
of LIVERPOOL
TORINO:
Stefano Bonora
Antonio D’Avolio
Mauro Sciandra
Marco Siccardi
Lorena Baietto
Cristina Tettoni
Sabrina Audagnotto
Letizia Marinaro
Jessica Cusato
Margherita Bracchi
Laura Trentini
Andrea Calcagno
Marco Simiele
Amedeo De Nicolò
Anna Lucchini
Filippo Lipani
Roberto Bertucci
Agostino Maiello
Bernardino Salassa
Francesco G. De Rosa
Chiara Montrucchio
Chiara Alcantarini
Chiara Cardellino
LIVERPOOL:
David Back
Saye Khoo
Andy Owen
Marco Siccardi
LONDON:
Marta Boffito
Margherita Bracchi
ROMA:
Andrea Antinori
Emanuele Nicastri
Giuseppe Ippolito
Alessandra Arialdo
Micol Ferrara
Alice Trentalange
Nicole Pagani
Lucio Boglione
Sarah Allegra
Debora Pensi
Pino Cariti
Paolo Bigliano
Ilaria Motta
Silvia Corcione
Maria Laura Stella
Valeria Ghisetti